Skip to main content

Eledon Pharmaceuticals, Inc.

ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001404281

No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of ELDN: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders83195+13
Shares36.5M59.6K44.2M+7.74M (+21.3%)
Value$94.5M$151.3K$66.7M−$27.6M (−29.3%)

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to ELDN in Q4 2025
InstitutionSharesValue% of portfolio
Defilade Capital Management, L.P.3,290,450$4.97M0.67%
ADAR1 Capital Management, LLC1,821,812$2.75M0.21%
Jefferies Financial Group Inc.1,580,625$2.39M0.02%
AWM Investment Company, Inc.1,100,000$1.66M0.16%
Kingdon Capital Management, L.L.C.1,039,275$1.57M0.24%
Stonepine Capital Management, LLC893,100$1.35M1.07%
SG Americas Securities, LLC627,392$947.0K0.00%
Caligan Partners LP555,978$839.5K0.08%
Colony Group, LLC317,443$479.3K0.00%
Brevan Howard Capital Management LP195,757$285.8K0.01%
Boothbay Fund Management, LLC151,569$228.9K0.01%
Graham Capital Management, L.P.70,260$106.1K0.00%
Daytona Street Capital LLC70,166$106.0K0.09%
PW Nova Financial Services LLC58,041$94.0K0.04%
AQR Capital Management LLC60,215$90.9K0.00%
Marshall Wace, LLP29,547$44.6K0.00%
Canada Pension Plan Investment Board29,400$44.4K0.00%
Virtu Financial LLC25,920$39.0K0.00%
Millennium Management LLC23,788$35.9K0.00%
Two Sigma Securities, LLC19,345$29.2K0.00%
Tiaa Trust, National Association19,000$28.7K0.00%
Mariner, LLC12,414$18.7K0.00%
Raymond James Financial Inc10,600$16.0K0.00%
ProShare Advisors LLC10,266$15.5K0.00%
Forum Private Client Group LLC10,000$15.1K0.01%
Split Rock Private Trading & Wealth Management, LLC10,000$15.1K0.01%
Seven Fleet Capital Management LP6,000$9.06K0.01%
Clearstead Advisors, LLC500$7550.00%
EverSource Wealth Advisors, LLC349$5270.00%
Essential Partners LLC331$5000.00%
Rothschild Investment LLC24$360.00%
Byrne Asset Management LLC1$20.00%

Sold out (19)

Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (1)

Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ELDN in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Wolverine Trading, LLC59,574$151.3K